Skip to content
zameds

Lisdexamfetamine

Also known as: Lisdexamphetamine

Schedule 6 to 7, conditions apply
Loading the molecular structure
C15H25N3O263.38 g/mol

(2S)-2,6-Diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide

Drag to rotate. Structure from PubChem CID 11597698.

Background

Loading...
Loading Wikipedia summary

Listing

Schedules
Schedule 6 to 7, conditions apply
Source
Consolidated Schedules 06 July 2026

Registered medicines

1 registered product listed

Counted through the register's ingredient index, which does not reach every record.

Registered products
NameBrandsDosagesApplicantsRegistrationsSchedule
Lisdexamfetamine dimesilateVyvanse, Vyfocis, Dystralex, +1 more30 mg, 50 mg, 70 mg3 applicants12 registrationsS6 to S7conditions apply

Regulatory status

Where S6 to S7 sits on the scale

Depends on which listing applies

At the least restrictive, Schedule 6: prescription-only, no repeats without a new prescription. At the most restrictive, Schedule 7: prohibited outside a government permit. The listings below say which applies to which form, strength or pack size.

Schedule S6 to S7, as the Consolidated Schedules list it.

Who may supply: Nobody, except under a permit issued by the Director-General. The Director-General may also authorise a medical practitioner, analyst, researcher or veterinarian to acquire or use it, on prescribed conditions, for the treatment or prevention of a medical condition in a particular patient, or for education, analysis or research. An ordinary prescription does not apply.

Consolidated Schedules listings for Lisdexamfetamine

  • S7: Lisdexamfetamine (Lisdexamphetamine)

    • except in medicines registered in terms of the Act and intended for the treatment of Attention-Deficit Hyperactivity Disorder. (S6)

    Consolidated Schedules 06 July 2026, lines 10751 to 10752

  • S6: Lisdexamfetamine (Lisdexamphetamine)

    • in medicines registered in terms of the Act and intended for the treatment of Attention-Deficit Hyperactivity Disorder. (S7)

    Consolidated Schedules 06 July 2026, lines 10289 to 10290

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Research articles

Loading...
Loading PubMed articles